Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-11-25
2009-11-24
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S301000, C514S302000, C514S303000, C546S114000, C546S115000, C546S116000, C546S118000
Reexamination Certificate
active
07622479
ABSTRACT:
The present invention provides a heterocyclic compound having potent tyrosine kinase-inhibiting activity represented by formula:(wherein, R1bis a C6-10aryl group which has substituent(s), and the like; Tais a single bond, a C1-6alkyl group, —CH2O—, and the like; X and Y are the same or different, and each is a nitrogen atom which may have substituent(s), and the like; the broken line is a single bond or a double bond; Zais a nitrogen atom or CH; W is a single bond, an oxygen atom, and the like; Q is a C6-10aryl group which may have substituent(s) or an aromatic heterocyclic group which may have substituent(s)); or a salt thereof and a pharmaceutical composition comprising thereof.
REFERENCES:
patent: 4659360 (1987-04-01), Baum et al.
patent: 5665737 (1997-09-01), Cavalla et al.
patent: 6211215 (2001-04-01), Momose et al.
patent: 2002/0107269 (2002-08-01), Bonham
patent: 2002/0173526 (2002-11-01), Tasaka et al.
patent: 2011222 (1990-09-01), None
patent: 0385850 (1990-09-01), None
patent: 1388102 (1973-02-01), None
patent: 2008108 (1979-05-01), None
patent: 2000-351769 (2000-12-01), None
patent: 2002-179568 (2002-06-01), None
patent: WO 99/16755 (1999-04-01), None
patent: WO 02/22598 (2002-03-01), None
K. Soderlind, et al., “Bis-benzimidazole anticancer agents: targeting human tumour helicases”, Anti-Cancer Drug Design, 14(1): 19-36 (1999).
R. Dow, et al., “Benzyloxazolidine-2,4-diones as Potent Hypoglycemic Agents”, J. Med. Chem. 34(5): 1538-1544 (1991).
T. Gungor, et al., “Cardiotonic Agents. Synthesis and Cardiovascular Properties of Novel 2-Arylbenzimidazoles and Azabenzimidazoles”, J. Med. Chem., (1992, 35: 4455-4463.
Y. Bathini, et al., “Molecular Recognition between Ligands and Nucleic Acids: Novel Pyridine- and Benzoxazole-Containing Agents Related to Hoechst . . . , etc.”, Chem. Res. Toxicol, (1990), 3: 268-280.
R. Troschutz, et al., “Synthese von 5-Methyl-und 5-Phenyl-Sulmazol”, Archiv der Pharmazie, (1992), 325(9): 617-619.
R. Gupta, et al., “Design, synthesis, DNA Sequence Preferential Alkylation and Biologivcal Evaluation of N-mustard Derivatives of Hoechst 33258 Analogues”, Anti-Cancer Drug Design, (1995), 10: 25-41.
Furuya Shuichi
Imada Takashi
Naito Ken-ichiro
Oda Tsuneo
Tamura Toshiya
Hamre Schumann Mueller & Larson P.C.
Sackey Ebenezer
Takeda Pharmaceutical Company Limited
Wilson James O
LandOfFree
Bicyclic derivative, its production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic derivative, its production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic derivative, its production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4124497